1,714
Participants
Start Date
May 31, 2009
Primary Completion Date
June 30, 2012
Study Completion Date
September 30, 2013
Brivanib
Tablets, Oral, 800 mg, Once Daily, Until disease progression or unacceptable toxicity
Placebo
Capsules, Oral, twice Daily, Until disease progression or unacceptable toxicity
Sorafenib
Capsules, Oral, 800 mg, twice daily, Until disease progression or unacceptable toxicity
Placebo
Tablets, Oral, Once Daily, Until disease progression or unacceptable toxicity
Local Institution, Taipei
Local Institution, Taipei
Local Institution, Taoyuan District
Local Institution, Taichung
Local Institution, Changhua
Local Institution, Kaohsiung City
Local Institution, Caba
Local Institution, Rosario
Local Institution, Camperdown
Local Institution, Concord
Local Institution, Westmead Nsw
Local Institution, Prahan
Local Institution, Parkville
Local Institution, Liège
Local Institution, Durban
Local Institution, Cape Town
Local Institution, Rondebosch
Local Institution, Observatory, Cape Town
Local Institution, Shatin
Local Institution, Hong Kong
Local Institution, Bangkok
Local Institution, Bangkok
Local Institution, Marseille
Local Institution, Berlin
Local Institution, Marseille
Local Institution, Tlalpan
Local Institution, D.f.
Local Institution, Santiago de Compostela
Thomas Jefferson Univ., Philadelphia
Local Institution, Milan
Local Institution, Milan
Local Institution, Aguascalientes
Local Institution, Hamburg
Mcguire Dvamc, Richmond
Local Institution, Bordeaux
Medical Specialists Of Palm Beaches, Lake Worth
Local Institution, Rennes
Local Institution, Izmir
Local Institution, Kayseri
Local Institution, Grenoble
Local Institution, Magdeburg
James Graham Brown Cancer Center, Louisville
3912 Taubman Center, Ann Arbor
Karmanos Cancer Institute, Detroit
University Of Wisconsin, Madison
Local Institution, Vandœuvre-lès-Nancy
Local Institution, Pisa
Local Institution, Lille
Local Institution, Torrette -Ancona
Local Institution, Monterrey
Local Institution, Lyon
Local Institution, Tainan R.o.c.
Univ Of Ark For Med Sci, Little Rock
Local Institution, Paris
Local Institution, Paris
Local Institution, Paris
Local Institution, Napoli
Local Institution, Gdansk
Mayo Clinic Arizona, Scottsdale
Local Institution, Ulm
Agajanian Institute Of Hematology And Oncology, Downey
Local Institution, Clichy
Sharp Clinical Oncology Research, San Diego
Local Institution, Créteil
Local Institution, Beijing
Local Institution, Beijing
Local Institution, Beijing
Local Institution, Moscow
Local Institution, Dalian
Local Institution, Moscow
Local Institution, Moscow
Local Institution, Hangzhou
Local Institution, Shanghai
Local Institution, Nanjing
Local Institution, Nanjing
Local Institution, Nanjing
Local Institution, Changzhou
Local Institution, Suzhou
Local Institution, Ahmedabad
Local Institution, Mumbai
Local Institution, Mumbai
Local Institution, Chongqing
Local Institution, Changsha
Local Institution, Pune
Local Institution, Wuhan
Local Institution, Hyderabad
Local Institution, Hyderabad
Local Institution, Guanzhou
Local Institution, Guangzhou
Local Institution, Nanning
Local Institution, Chennai
Local Institution, Chengdu
Local Institution, Coimbatore
Local Institution, Kochi
Local Institution, Trivandrum
Local Institution, Kolkata
Local Institution, Xi'an
Local Institution, Kawasaki-shi
Local Institution, Tsu
Local Institution, Higashinari-ku
Local Institution, Osaka
Local Institution, Osaka
Local Institution, Ōsaka-sayama
Local Institution, Nishinomiya-shi
Local Institution, Okayama
Local Institution, Shimonoseki-shi
Local Institution, Kanazawa
Va Ct Healthcare System, West Haven
Local Institution, Buenos Aires
Local Institution, Capital Federal
Local Institution, Fortaleza
Local Institution, Salvador
Local Institution, Salvador - Ba
Local Institution, Goiânia
Local Institution, Divinópolis
Local Institution, Curitiba
Local Institution, Porto Alegre
Local Institution, Porto Alegre
Local Institution, Porto Alegre
Local Institution, Barretos
Local Institution, Jaú
Local Institution, São Paulo
Local Institution, Calgary
Local Institution, Vancouver
Local Institution, London
Local Institution, Montreal
Local Institution, Brno
Local Institution, Prague
Local Institution, Prague
Local Institution, Halle
Local Institution, Kolkata
Local Institution, New Delhi
Local Institution, Roma
Local Institution, Kashiwa-shi
Local Institution, Sapporo
Local Institution, Yokohama
Local Institution, Osaka
Local Institution, Sunto-gun
Local Institution, Chuo-Ku
Local Institution, Minato-ku
Local Institution, Musashino-shi
Local Institution, D.f.
Local Institution, Distrito Federal
Local Institution, Mexico City
Local Institution, Gliwice
Local Institution, Krakow
Local Institution, Warsaw
Local Institution, San Juan
Local Institution, Moscow
Local Institution, Pretoria
Local Institution, Busan
Local Institution, Daegu
Local Institution, Gyeonggi-do
Local Institution, Kyunggi-do
Local Institution, Seoul
Local Institution, Seoul
Local Institution, Seoul
Local Institution, Seoul
Local Institution, Seoul
Local Institution, Alicante
Local Institution, Barcelona
Local Institution, Stockholm
Local Institution, Uppsala
Local Institution, Ankara
Local Institution, Antalya
Local Institution, Istanbul
Local Institution, Bristol
Local Institution, London
Local Institution, London
Local Institution, London
Local Institution, Manchester
Local Institution, Birmingham
Local Institution, Leeds
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY